4//SEC Filing
CR Group L.P. 4
Accession 0001415889-24-004167
CIK 0001492674other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:17 PM ET
Size
19.2 KB
Accession
0001415889-24-004167
Insider Transaction Report
Form 4
Capital Royalty L.P.
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2024-02-14−33,594.71→ 0 total(indirect: By: CRG Partners III (Cayman) Lev AIV I L.P.)From: 2023-07-03→ Common Stock (335,947 underlying) - Conversion
Common Stock
2024-02-14+335,947→ 335,947 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Conversion
Common Stock
2024-02-14+488,273→ 488,273 total(indirect: By: CRG Partners III Parallel Fund B LP) - Conversion
Series B Preferred Stock
2024-02-14−48,827.3→ 10,875.25 total(indirect: By: CRG Partners III Parallel Fund B LP)From: 2023-07-03→ Common Stock (488,273 underlying)
Transactions
- Conversion
Series B Preferred Stock
2024-02-14−33,594.71→ 0 total(indirect: By: CRG Partners III (Cayman) Lev AIV I L.P.)From: 2023-07-03→ Common Stock (335,947 underlying) - Conversion
Common Stock
2024-02-14+335,947→ 335,947 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Conversion
Common Stock
2024-02-14+488,273→ 488,273 total(indirect: By: CRG Partners III Parallel Fund B LP) - Conversion
Series B Preferred Stock
2024-02-14−48,827.3→ 10,875.25 total(indirect: By: CRG Partners III Parallel Fund B LP)From: 2023-07-03→ Common Stock (488,273 underlying)
Transactions
- Conversion
Common Stock
2024-02-14+488,273→ 488,273 total(indirect: By: CRG Partners III Parallel Fund B LP) - Conversion
Series B Preferred Stock
2024-02-14−33,594.71→ 0 total(indirect: By: CRG Partners III (Cayman) Lev AIV I L.P.)From: 2023-07-03→ Common Stock (335,947 underlying) - Conversion
Series B Preferred Stock
2024-02-14−48,827.3→ 10,875.25 total(indirect: By: CRG Partners III Parallel Fund B LP)From: 2023-07-03→ Common Stock (488,273 underlying) - Conversion
Common Stock
2024-02-14+335,947→ 335,947 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.)
Transactions
- Conversion
Series B Preferred Stock
2024-02-14−33,594.71→ 0 total(indirect: By: CRG Partners III (Cayman) Lev AIV I L.P.)From: 2023-07-03→ Common Stock (335,947 underlying) - Conversion
Common Stock
2024-02-14+488,273→ 488,273 total(indirect: By: CRG Partners III Parallel Fund B LP) - Conversion
Common Stock
2024-02-14+335,947→ 335,947 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Conversion
Series B Preferred Stock
2024-02-14−48,827.3→ 10,875.25 total(indirect: By: CRG Partners III Parallel Fund B LP)From: 2023-07-03→ Common Stock (488,273 underlying)
Transactions
- Conversion
Series B Preferred Stock
2024-02-14−33,594.71→ 0 total(indirect: By: CRG Partners III (Cayman) Lev AIV I L.P.)From: 2023-07-03→ Common Stock (335,947 underlying) - Conversion
Common Stock
2024-02-14+335,947→ 335,947 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Conversion
Series B Preferred Stock
2024-02-14−48,827.3→ 10,875.25 total(indirect: By: CRG Partners III Parallel Fund B LP)From: 2023-07-03→ Common Stock (488,273 underlying) - Conversion
Common Stock
2024-02-14+488,273→ 488,273 total(indirect: By: CRG Partners III Parallel Fund B LP)
CRG Partners III L.P.
10% Owner
Transactions
- Conversion
Common Stock
2024-02-14+335,947→ 335,947 total(indirect: By CRG Partners III (Cayman) Lev AIV I L.P.) - Conversion
Series B Preferred Stock
2024-02-14−33,594.71→ 0 total(indirect: By: CRG Partners III (Cayman) Lev AIV I L.P.)From: 2023-07-03→ Common Stock (335,947 underlying) - Conversion
Common Stock
2024-02-14+488,273→ 488,273 total(indirect: By: CRG Partners III Parallel Fund B LP) - Conversion
Series B Preferred Stock
2024-02-14−48,827.3→ 10,875.25 total(indirect: By: CRG Partners III Parallel Fund B LP)From: 2023-07-03→ Common Stock (488,273 underlying)
Footnotes (3)
- [F1]Each share of Series B Preferred Stock converted into 10 shares of Common Stock for no additional consideration.
- [F2]CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.
- [F3]The preferred stock has no expiration date.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001702352
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:17 PM ET
- Size
- 19.2 KB